This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.
Jerry Mizell
Advertisement
Jerry Mizell is director of analytical services at Metrics Corp.
Articles by Jerry Mizell
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
Potent APIs Amplify Carryover Risk: AAPS PharmSci 360 2026
5